These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36372061)

  • 1. Expert provider survey of longitudinal assessment in patients with pulmonary arterial hypertension.
    Kingrey JF; Zhou CY; Dalal B; Elwing JM
    Heart Lung; 2023; 58():34-38. PubMed ID: 36372061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Knowledge, Attitude, and Practice Patterns in Pulmonary Arterial Hypertension among Cardiologists and Pulmonologists: Evidence from Turkey.
    Günaydın FE; Belen E; Altın S; Demir AU; Güven G; Durmuş G
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893587
    [No Abstract]   [Full Text] [Related]  

  • 3. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
    Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
    J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for pulmonary arterial hypertension in adults carrying a
    Montani D; Girerd B; Jaïs X; Laveneziana P; Lau EMT; Bouchachi A; Hascoët S; Günther S; Godinas L; Parent F; Guignabert C; Beurnier A; Chemla D; Hervé P; Eyries M; Soubrier F; Simonneau G; Sitbon O; Savale L; Humbert M
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33380512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 6. The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey.
    Small M; Perchenet L; Bennett A; Linder J
    Ther Adv Respir Dis; 2024; 18():17534666231218886. PubMed ID: 38357903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.
    Duarte AG; Lin YL; Sharma G
    J Heart Lung Transplant; 2017 Feb; 36(2):220-226. PubMed ID: 27595194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serial right heart catheterization in risk stratification and management of pulmonary arterial hypertension.
    Sharma D; Shah RJ; Sreenivasan J; Kafle P; Gupta R; Levine A; Lanier GM; Aronow WS
    Expert Rev Cardiovasc Ther; 2022 Jul; 20(7):543-547. PubMed ID: 35726644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
    Farmakis IT; Vazakidis P; Doundoulakis I; Arvanitaki A; Zafeiropoulos S; Boutou A; Karvounis H; Giannakoulas G
    Pulm Pharmacol Ther; 2021 Jun; 68():102036. PubMed ID: 33979684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
    Takatsuki S; Wagner BD; Ivy DD
    Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
    Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap.
    McLaughlin VV; Langer A; Tan M; Clements PJ; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ;
    Chest; 2013 Feb; 143(2):324-332. PubMed ID: 22910999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECG in the clinical and prognostic evaluation of patients with pulmonary arterial hypertension: an underestimated value.
    Michalski TA; Pszczola J; Lisowska A; Knapp M; Sobkowicz B; Kaminski K; Ptaszynska-Kopczynska K
    Ther Adv Respir Dis; 2022; 16():17534666221087846. PubMed ID: 35442108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.
    Fauvel C; Raitiere O; Boucly A; De Groote P; Renard S; Bertona J; Lamblin N; Artaud-Macari E; Viacroze C; Schleifer D; Dominique S; Pichon J; Jais X; Montani D; Sitbon O; Savale L; Humbert M; Bauer F
    J Heart Lung Transplant; 2022 Dec; 41(12):1761-1772. PubMed ID: 36202691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Risk of Disease Progression in Pulmonary Arterial Hypertension: Insights from an International Survey of Clinical Practice.
    Simons JE; Mann EB; Pierozynski A
    Adv Ther; 2019 Sep; 36(9):2351-2363. PubMed ID: 31313097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pulmonary hypertension gas exchange severity (PH-GXS) score to assist with the assessment and monitoring of pulmonary arterial hypertension.
    Woods PR; Taylor BJ; Frantz RP; Johnson BD
    Am J Cardiol; 2012 Apr; 109(7):1066-72. PubMed ID: 22245407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.
    Chandrasekara S; Lau EM; Anderson J; Collins N; Cordina R; Corrigan C; Dwyer N; Feenstra J; Horrigan M; Keogh A; Kotlyar E; Lavender M; McWilliams T; Rhodes B; Steele P; Strange G; Thakkar V; Weintraub R; Whitford H; Whyte K; Williams T; Wrobel J; Keating DT;
    Heart Lung Circ; 2023 Feb; 32(2):156-165. PubMed ID: 36503731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension].
    Zhang XM; Zhuang Q; Yang MH; Wang W; Zheng Y; Qiao ZQ; Shen JY; Shen XD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Dec; 46(12):965-971. PubMed ID: 30572401
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of Adults With Congenital Heart Disease and Pulmonary Arterial Hypertension in the UK: Survey of Current Practice, Unmet Needs and Expert Commentary.
    Tulloh R; Dimopoulos K; Condliffe R; Clift P;
    Heart Lung Circ; 2018 Aug; 27(8):1018-1027. PubMed ID: 29191503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.